Skip to content
Recall Observatory FDA recall evidence

Drug product

Amlodipine Besylate USP 10 mg Tablets, 1000-count bottles, Rx Only, Manufactured by: Cipla Ltd., Verna Goa, India, Manufactured for: Cipla USA, Inc. 1560 Sawgrass Corporate Parkway, Suite 130, Sunrise FL 33323 UPC 369097128159, NDC 69097-128-15

D-0012-2019

October 03, 2018

Class III

Product summary

Firm
InvaGen Pharmaceuticals, Inc.
Event
Event 81099
Status
Terminated
Classification
Class III
Quantity
2880 bottles
Official record key
drug-enforcement:D-0012-2019

Official wording

Reason: Subpotent Drug: One lot of product does not meet the product specification for Assay test at 3 month long term stability condition.

Code information: Lot #: GG80218, Exp. 12/2019

Distribution pattern: Nationwide with the United States

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Subpotent